drugset / Trial / NCT01409408

Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

NCT01409408

RandomizedParallel-groupDouble-blindTreatment

Summary

Assess if aliskiren is capable of enhancing vascular stiffness and endothelial function and compare theses effects and renin activity and concentration to those obtained with a calcium channel blocker, amlodipine, in patients with diabetes mellitus type 2 and blood pressure not controlled by 100 mg per day of losartan.

Timeline

Start
2011-04
Primary completion
2013-04
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 300 mg
Comparator Amlodipine Other / unclassified 5 mg